OrbusNeich Medical Company Limited
OrbusNeich Medical Company Limited, headquartered in Hong Kong, is a leading innovator in the medical device industry, specialising in cardiovascular and peripheral interventions. Founded in 2006, the company has established a strong presence in key markets across Asia, Europe, and the Americas, focusing on the development of advanced solutions for complex vascular conditions. OrbusNeich is renowned for its cutting-edge products, including drug-eluting stents and balloon catheters, which are designed to enhance patient outcomes through superior performance and safety. The company’s commitment to research and development has positioned it as a trusted partner in the medical community, achieving significant milestones in product innovation and regulatory approvals. With a reputation for excellence, OrbusNeich continues to lead the way in transforming cardiovascular care globally.
DitchCarbon Score
How does OrbusNeich Medical Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OrbusNeich Medical Company Limited's score of 20 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OrbusNeich Medical Company Limited's reported carbon emissions
In 2023, OrbusNeich Medical Company Limited reported total carbon emissions of approximately 3,921,300 kg CO2e, with Scope 1 emissions at about 69,810 kg CO2e and Scope 2 emissions at approximately 3,851,490 kg CO2e. This represents an increase from 2022, where total emissions were about 3,444,610 kg CO2e, with Scope 1 emissions of around 81,870 kg CO2e and Scope 2 emissions of approximately 3,362,740 kg CO2e. Despite the increase in emissions, OrbusNeich has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has reported emissions data for Scope 1 and Scope 2 but has not provided information regarding Scope 3 emissions. As a medical device manufacturer headquartered in Hong Kong, OrbusNeich is positioned within an industry that is increasingly focused on sustainability and climate commitments. However, without defined reduction targets or climate pledges, the company's future commitments to reducing carbon emissions remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 81,870 | 00,000 |
| Scope 2 | 3,362,740 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OrbusNeich Medical Company Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
